|
Įkelta: 2012-02-06 Peržiūrėjo: 14 Patiko: (SPA, BLRX, SURW) CRWENewswire Stocks In ActionBioLineRx Ltd BLRX - reported that it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030 KomentaraiPrašome palaukti...
|

.jpg)
.jpg)